DIGITAL HEALTH: Enabling the Future of Medicine

Digital Health promises to transform the practice of medicine by allowing continuous real-time patient monitoring, offering innovative digital therapeutics and combination products, and enabling patient-centric clinical research and healthcare. The Digital Health conference brings together the key thought leaders in enabling technologies, pharma, healthcare, investors, and entrepreneurs to foster collaboration and innovation in digitalization of medicine. The Digital Health Tech program will focus on the advances in enabling technologies, including sensors and wearables, apps and SaMD, artificial intelligence and machine learning, Internet of Medical Things, devices and apps for compliance and safety monitoring, and utility of smartphones and smartwatches for remote patient monitoring. The parallel Digital Medicine program will highlight the latest innovations in digital therapeutics and digital companions, connected diagnostics, digital biomarkers, Real World Evidence and clinical research, and the impact on big pharma and drug development. The meeting will also address the business strategies and value generation, commercialization and market access, regulatory and reimbursement strategies, as well as investment opportunities.

2020 Speakers


Ashish Atreja, MD, MPH
Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai


Yu-Feng (Yvonne) Chan, MD, PhD
Director, Digital Health & Personalized Medicine, Icahn Institute for Genomics and Multiscale Biology at Mt. Sinai


Adrian Chernoff
Former Worldwide Vice President, Global Head of Research and Development, Johnson and Johnson


Ray Dorsey, MD
Director, CHeT, University of Rochester


Mariya Filipova
Vice President, Innovation, Anthem, Inc.


Maryam Gholami
Vice President, Digital Innovation Group, Providence St. Joseph Health


Kyle Holen
Head, Development Design Center, AbbVie

Christopher M. Hartshorn, PhD
Director, Cancer Treatment and Diagnosis, NCI


Claus Jensen
CTO & Head of Architecture, CVS Health/Aetna


Dan Karlin, MD
CEO, HealthMode


Thomas Kluz, MS
General Partner, dRx Capital; Head, Healthcare Investing, Qualcomm Ventures

Michael Latauska
Director, Digital Health, Boehringer Ingelheim


Darin Oppenheimer
Executive Director, Regulatory Affairs & Digital Health Solutions, Merck


Søren Smed Østergaard
Vice President, Digital Health, Novo Nordisk

Raj Pallapothu
mHealth Global Lead, Bayer


Shrawan Patel
Vice President & Head, Clinical Transformation, Rx.Health

Joel Sangerman
Chief Commercial Officer, Click Therapeutics, Inc.


Dirk Schapeler
Vice President, Digital Innovation, Bayer Healthcare


Samir A. Shah, PhD
Associate Director, Regulatory Affairs, Teva Pharmaceuticals

Michael Snyder, PhD
Professor, Genomics & Personalized Medicine, Stanford University

Present a Poster - SAVE $100

We encourage attendees to gain further exposure by presenting their work in the Molecular Medicine Tri-Conference Poster Session.

Reasons to present your research poster

  • Your research will be seen by leaders from top pharmaceutical, biotech, academic and government institutes
  • Your poster abstract will be published in the conference materials
  • $100 off your registration fee
  • Your poster will be automatically entered in the People’s Choice Poster Awards, at which poster winner will receive $250

> Learn More

Premier Sponsors

> View All Sponsors